Records containing: Influenza
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-02-13The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and Infection Adaptive Immune Responses and Repertoire in Influenza Vaccination and Infection
-
CLINICAL_TRIALS study record update · 2020-02-12Sanofi Pasteur Quadrivalent Influenza Vaccine Pregnancy Registry Protocol
-
CLINICAL_TRIALS study record update · 2020-02-12Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry Protocol
-
CLINICAL_TRIALS study record update · 2020-02-10A Phase III, Open, Randomized, Multicenter, Comparative Vaccination Study to Evaluate the Immunogenicity and Reactogenicity of Various Formulations of a Monovalent Candidate Pandemic Influenza A Vaccine in Individuals Over 60 Years of Age
-
CLINICAL_TRIALS study record update · 2020-02-07Extra-pulmonary Clinical Manifestations of Influenza Virus and Respiratory Syncitial Virus Infections
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-02-05A Phase II, Double-Blind, Multicenter, Randomized, Placebo-Controlled Trial to Assess the Safety, Reactogenicity and Immunogenicity of Two Doses of Multimeric-001 (M-001) Followed by Seasonal Quadrivalent Influenza Vaccine
-
CLINICAL_TRIALS study record update · 2020-01-27A Randomised, Double Blind Study To Characterise Influenza A/Perth/16/2009(H3N2) Virus
-
CLINICAL_TRIALS study record update · 2020-01-18Is Invasive Pulmonary Aspergillosis a Common Complication of Severe Influenza ?
-
CLINICAL_TRIALS study record update · 2020-01-18A Phase 1/2a Clinical Study to Evaluate the Efficacy of MEDI8852 in the Treatment of Influenza in Adults Challenged With a Wild-Type Influenza Strain
-
CLINICAL_TRIALS study record update · 2020-01-10Incidence of Influenza Infections and Determination of Vaccination Coverage Rate Among Hospital and GPs Healthcare Workers During the 2019/2020 Epidemic Season
-
CLINICAL_TRIALS study record update · 2020-01-10Increasing Vaccine Uptake Among Veterans at the Atlanta VA Health Care System Through a Randomized Trial
-
CLINICAL_TRIALS study record update · 2019-12-26A Phase 4, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety of 2 New of 6:2 Influenza Virus Reassortants in Adults
-
CLINICAL_TRIALS study record update · 2019-12-17A Phase 1, Open Label, Ascending Dose Cohort Study of the Pharmacokinetics of Anti-Influenza Hyperimmune Intravenous Immunoglobulin in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2019-12-17VRC 315: A Phase I Open-Label, Randomized Study of H7 Influenza Prime-Boost Regimens in Healthy Adults: Recombinant H7 DNA Plasmid Vaccine, VRC-FLUDNA071-00-VP, Administered Alone or With Monovalent Influenza Subunit Virion H7N9 Vaccine (MIV) as Prime With MIV Boost Compared to MIV Prime With MIV Boost
-
CLINICAL_TRIALS study record update · 2019-12-17Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Participants Aged 65 Years and Older
-
CLINICAL_TRIALS study record update · 2019-12-17Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular or Subcutaneous Route in Participants Aged 65 Years and Older in Japan
-
CLINICAL_TRIALS study record update · 2019-12-13Project IMPACT Immunizations (IMProving America's Communities Together) Scaled Demonstration
-
CLINICAL_TRIALS study record update · 2019-11-25Safety and Immunogenicity of Fluzone® Quadrivalent, Flublok® Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines, 2018-2019 Formulations
-
CLINICAL_TRIALS study record update · 2019-11-19A Phase I, Open-label, Ascending Dose Study to Determine the Safety and Reactogenicity of a Wild Type Seasonal A/California/ H1N1 2009 Influenza Challenge Virus in Healthy Volunteers, Following a Single Intranasal Administration
-
CLINICAL_TRIALS study record update · 2019-11-06A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Patients With Influenza at High Risk of Influenza Complications
-
CLINICAL_TRIALS study record update · 2019-11-04Multicenter Double-blinded Placebo-Controlled Parallel-Group Randomized Clinical Trial of Efficacy, Safety and Choice of an Optimum Dose of XC221 in the Treatment of Influenza and Other Acute Respiratory Viral Infections in Adults
-
CLINICAL_TRIALS study record update · 2019-11-01Association of Lung Bacteriobiota With Intensive Care Unit Mortality in ARDS Patients: MicroFlu Study
-
CLINICAL_TRIALS study record update · 2019-10-28Reactogenicity and Immunogenicity Study of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1119711A) Administered According to Different Vaccination Schedules
-
CLINICAL_TRIALS study record update · 2019-10-25The Oakland Men's Health Disparities Study
-
CLINICAL_TRIALS study record update · 2019-10-23A Phase I Randomized, Double-Blind, Controlled Trial in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of a Monovalent Inactivated Influenza A/H5N8 Virus Vaccine Administered Intramuscularly at Different Dosages Given With or Without AS03 or MF59 Adjuvants